SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-032772
Filing Date
2021-06-14
Accepted
2021-06-14 16:00:43
Documents
12
Period of Report
2021-06-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K cue-8k_20210609.htm   iXBRL 8-K 80452
  Complete submission text file 0001564590-21-032772.txt   211436

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cue-20210609.xsd EX-101.SCH 5789
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cue-20210609_lab.xml EX-101.LAB 19466
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cue-20210609_pre.xml EX-101.PRE 11637
5 EXTRACTED XBRL INSTANCE DOCUMENT cue-8k_20210609_htm.xml XML 3538
Mailing Address 21 ERIE STREET CAMBRIDGE MA 02139
Business Address 21 ERIE STREET CAMBRIDGE MA 02139 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 211014552
SIC: 2834 Pharmaceutical Preparations